Preliminary evidence that daily light exposure enhances the antibody response to influenza vaccination in patients with dementia

Enhancing lighting conditions in institutions for individuals with dementia improves their sleep, circadian rhythms and well-being. Here, we report first findings that exposure to brighter light during daytime may support the immune response to the annual influenza vaccination. Eighty older institut...

Full description

Bibliographic Details
Main Authors: Mirjam Münch, Rolf Goldbach, Naomi Zumstein, Petra Vonmoos, Jean-Louis Scartezzini, Anna Wirz-Justice, Christian Cajochen
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:Brain, Behavior, & Immunity - Health
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666354622001053
_version_ 1797991275886018560
author Mirjam Münch
Rolf Goldbach
Naomi Zumstein
Petra Vonmoos
Jean-Louis Scartezzini
Anna Wirz-Justice
Christian Cajochen
author_facet Mirjam Münch
Rolf Goldbach
Naomi Zumstein
Petra Vonmoos
Jean-Louis Scartezzini
Anna Wirz-Justice
Christian Cajochen
author_sort Mirjam Münch
collection DOAJ
description Enhancing lighting conditions in institutions for individuals with dementia improves their sleep, circadian rhythms and well-being. Here, we report first findings that exposure to brighter light during daytime may support the immune response to the annual influenza vaccination. Eighty older institutionalised patients suffering from dementia (54 women and 26 men) continuously wore an activity tracker for 8 weeks to assess individual light exposure and rest-activity cycles. We analysed the patients’ immune response from two blood samples taken before and 4 weeks after the annual influenza vaccination. Individual antibody concentrations to three influenza virus strains (H3N2, H1N1, IB) were quantified via hemagglutination inhibition assays. By quantifying individual light exposure profiles (including daylight), we classified the patients into a low and a high light exposure group based on a median illuminance of 392.6 lux. The two light exposure groups did not differ in cognitive impairment severity, age or gender distribution. However, patients in the high light exposure group showed a significantly greater circadian rest-activity amplitude (i.e., more daytime activity and less nighttime activity) along with a significantly greater antibody titer increase to the H3N2 vaccine than patients in the low light exposure group, despite similar pre-vaccination concentrations. Sufficient seroprotective responses to all three influenza virus strains were attained for ≥75% of participants. These data provide preliminary evidence for a potentially enhanced immune response in patients with dementia when they received more daily light. Future studies are needed to determine whether regular daily light exposure may have beneficial effects on the human immune system, either directly or via a stabilising circadian sleep-wake rhythms.
first_indexed 2024-04-11T08:49:32Z
format Article
id doaj.art-55b8f860b8f74814b03d48245d0f1743
institution Directory Open Access Journal
issn 2666-3546
language English
last_indexed 2024-04-11T08:49:32Z
publishDate 2022-12-01
publisher Elsevier
record_format Article
series Brain, Behavior, & Immunity - Health
spelling doaj.art-55b8f860b8f74814b03d48245d0f17432022-12-22T04:33:37ZengElsevierBrain, Behavior, & Immunity - Health2666-35462022-12-0126100515Preliminary evidence that daily light exposure enhances the antibody response to influenza vaccination in patients with dementiaMirjam Münch0Rolf Goldbach1Naomi Zumstein2Petra Vonmoos3Jean-Louis Scartezzini4Anna Wirz-Justice5Christian Cajochen6Solar Energy and Building Physics Laboratory, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland; Centre for Chronobiology, Psychiatric Hospital of the University of Basel, Basel, Switzerland; Transfaculty Research Platform, Molecular and Cognitive Neurosciences, University of Basel, Basel, Switzerland; Corresponding author. Centre for Chronobiology Psychiatric Hospital of the University of Basel, Basel, Switzerland Transfaculty Research Platform Molecular and Cognitive Neurosciences University of Basel, Switzerland Wilhelm Klein-Strasse 27, CH-4002, Basel, Switzerland.Geriatric Service of the City of Zurich, Zurich, SwitzerlandDepartment of Anthropology, McGill University, Montreal, Canada; University Research Priority Program “Dynamics of Healthy Aging”, University of Zurich, Zurich, SwitzerlandSonnweid – the Home, Wetzikon, SwitzerlandSolar Energy and Building Physics Laboratory, Ecole Polytechnique Fédérale de Lausanne, Lausanne, SwitzerlandCentre for Chronobiology, Psychiatric Hospital of the University of Basel, Basel, SwitzerlandCentre for Chronobiology, Psychiatric Hospital of the University of Basel, Basel, Switzerland; Transfaculty Research Platform, Molecular and Cognitive Neurosciences, University of Basel, Basel, SwitzerlandEnhancing lighting conditions in institutions for individuals with dementia improves their sleep, circadian rhythms and well-being. Here, we report first findings that exposure to brighter light during daytime may support the immune response to the annual influenza vaccination. Eighty older institutionalised patients suffering from dementia (54 women and 26 men) continuously wore an activity tracker for 8 weeks to assess individual light exposure and rest-activity cycles. We analysed the patients’ immune response from two blood samples taken before and 4 weeks after the annual influenza vaccination. Individual antibody concentrations to three influenza virus strains (H3N2, H1N1, IB) were quantified via hemagglutination inhibition assays. By quantifying individual light exposure profiles (including daylight), we classified the patients into a low and a high light exposure group based on a median illuminance of 392.6 lux. The two light exposure groups did not differ in cognitive impairment severity, age or gender distribution. However, patients in the high light exposure group showed a significantly greater circadian rest-activity amplitude (i.e., more daytime activity and less nighttime activity) along with a significantly greater antibody titer increase to the H3N2 vaccine than patients in the low light exposure group, despite similar pre-vaccination concentrations. Sufficient seroprotective responses to all three influenza virus strains were attained for ≥75% of participants. These data provide preliminary evidence for a potentially enhanced immune response in patients with dementia when they received more daily light. Future studies are needed to determine whether regular daily light exposure may have beneficial effects on the human immune system, either directly or via a stabilising circadian sleep-wake rhythms.http://www.sciencedirect.com/science/article/pii/S2666354622001053ImmunologyFlu shotCircadianLightNeurodegenerationRest-activity
spellingShingle Mirjam Münch
Rolf Goldbach
Naomi Zumstein
Petra Vonmoos
Jean-Louis Scartezzini
Anna Wirz-Justice
Christian Cajochen
Preliminary evidence that daily light exposure enhances the antibody response to influenza vaccination in patients with dementia
Brain, Behavior, & Immunity - Health
Immunology
Flu shot
Circadian
Light
Neurodegeneration
Rest-activity
title Preliminary evidence that daily light exposure enhances the antibody response to influenza vaccination in patients with dementia
title_full Preliminary evidence that daily light exposure enhances the antibody response to influenza vaccination in patients with dementia
title_fullStr Preliminary evidence that daily light exposure enhances the antibody response to influenza vaccination in patients with dementia
title_full_unstemmed Preliminary evidence that daily light exposure enhances the antibody response to influenza vaccination in patients with dementia
title_short Preliminary evidence that daily light exposure enhances the antibody response to influenza vaccination in patients with dementia
title_sort preliminary evidence that daily light exposure enhances the antibody response to influenza vaccination in patients with dementia
topic Immunology
Flu shot
Circadian
Light
Neurodegeneration
Rest-activity
url http://www.sciencedirect.com/science/article/pii/S2666354622001053
work_keys_str_mv AT mirjammunch preliminaryevidencethatdailylightexposureenhancestheantibodyresponsetoinfluenzavaccinationinpatientswithdementia
AT rolfgoldbach preliminaryevidencethatdailylightexposureenhancestheantibodyresponsetoinfluenzavaccinationinpatientswithdementia
AT naomizumstein preliminaryevidencethatdailylightexposureenhancestheantibodyresponsetoinfluenzavaccinationinpatientswithdementia
AT petravonmoos preliminaryevidencethatdailylightexposureenhancestheantibodyresponsetoinfluenzavaccinationinpatientswithdementia
AT jeanlouisscartezzini preliminaryevidencethatdailylightexposureenhancestheantibodyresponsetoinfluenzavaccinationinpatientswithdementia
AT annawirzjustice preliminaryevidencethatdailylightexposureenhancestheantibodyresponsetoinfluenzavaccinationinpatientswithdementia
AT christiancajochen preliminaryevidencethatdailylightexposureenhancestheantibodyresponsetoinfluenzavaccinationinpatientswithdementia